Treating blood, blood products and/or organs under in vitro, and ex vivo condition, involves obtaining blood, blood products and/or organs from human or animal body and removing amyloid beta oligomers from products
Gegenstand der Erfindung ist die Behandlung von Blut, Blutprodukten und Organen zur Entfernung und/oder Entoxifizierung von Amyloid-Beta-Oligomeren.Method for treating blood, blood products and/or organs under in vitro, and ex vivo condition, involves obtaining blood, blood products and/or organs from human or animal body and removing amyloid beta oligomers from the products. Independent claims are included for the following: (1) kit for performing the above-cited method which comprises substrate with hydrophobic substances, standard solution, scavenger molecule, probe, substrate with scavenger molecules solutions and buffers； and (2) use of antibodies for removing amyloid beta oligomers comprising (a) retro-inverso sequence of amyloid beta oligomers and/or (b) multimerization domain of amyloid beta oligomers. ACTIVITY : Neuroprotective； Nootropic； Antiparkinsonian； Antidiabetic. No biological data given. MECHANISM OF ACTION : None given.
